Therapeutic drug monitoring in the past 40 years of the JAC

David  Reeves; Andrew Lovering; Alison Thomson

doi:10.1093/jac/dkw408

Therapeutic drug monitoring in the past 40 years of the JAC

David Reeves, Andrew Lovering, Alison Thomson

Strathclyde Institute Of Pharmacy And Biomedical Sciences

Research output: Contribution to journal › Editorial › peer-review

25 Citations (Scopus)

58 Downloads (Pure)

Abstract

Since the Journal was first published in 1975, papers addressing therapeutic drug monitoring (TDM) have been a regular feature. Initially they focused on laboratory aspects of drug concentration measurement then they changed more to the application of TDM in a clinical setting. Over its history, the Journal has provided its readership with the latest technological and scientific advances in TDM and has helped to drive changes in TDM that have directly impacted on patient care. These have varied from improvement in the quality of antimicrobial measurements through better identification of dosage regimens and TDM targets that help predict outcome and adverse events.

Original language	English
Pages (from-to)	3330-3332
Number of pages	5
Journal	Journal of Antimicrobial Chemotherapy
Volume	71
Issue number	12
DOIs	https://doi.org/10.1093/jac/dkw408
Publication status	Published - 1 Dec 2016

Keywords

therapeutic drug monitoring
drug assay
antimicrobials

Access to Document

10.1093/jac/dkw408

Reeves-Lovering-Thomson-JAC-2016-therapeutic-drug-monitoring-in-the-past-40-years-of-the-JACAccepted author manuscript, 360 KB

Cite this

@article{fb393df27a794315a8ef8990bcb3d311,

title = "Therapeutic drug monitoring in the past 40 years of the JAC",

abstract = "Since the Journal was first published in 1975, papers addressing therapeutic drug monitoring (TDM) have been a regular feature. Initially they focused on laboratory aspects of drug concentration measurement then they changed more to the application of TDM in a clinical setting. Over its history, the Journal has provided its readership with the latest technological and scientific advances in TDM and has helped to drive changes in TDM that have directly impacted on patient care. These have varied from improvement in the quality of antimicrobial measurements through better identification of dosage regimens and TDM targets that help predict outcome and adverse events. ",

keywords = "therapeutic drug monitoring, drug assay, antimicrobials",

author = "David Reeves and Andrew Lovering and Alison Thomson",

note = "This is a pre-copyedited, author-produced PDF of an article accepted for publication in Journal of Antimicrobial Chemotherapy following peer review. The version of record Reeves, D., Lovering, A., & Thomson, A. (2016). Therapeutic drug monitoring in the past 40 years of the JAC. Journal of Antimicrobial Chemotherapy, 71(12), 3330-3332. DOI: 10.1093/jac/dkw408",

year = "2016",

month = dec,

day = "1",

doi = "10.1093/jac/dkw408",

language = "English",

volume = "71",

pages = "3330--3332",

journal = "Journal of Antimicrobial Chemotherapy",

issn = "0305-7453",

publisher = "Oxford University Press",

number = "12",

}

TY - JOUR

T1 - Therapeutic drug monitoring in the past 40 years of the JAC

AU - Reeves, David

AU - Lovering, Andrew

AU - Thomson, Alison

N1 - This is a pre-copyedited, author-produced PDF of an article accepted for publication in Journal of Antimicrobial Chemotherapy following peer review. The version of record Reeves, D., Lovering, A., & Thomson, A. (2016). Therapeutic drug monitoring in the past 40 years of the JAC. Journal of Antimicrobial Chemotherapy, 71(12), 3330-3332. DOI: 10.1093/jac/dkw408

PY - 2016/12/1

Y1 - 2016/12/1

N2 - Since the Journal was first published in 1975, papers addressing therapeutic drug monitoring (TDM) have been a regular feature. Initially they focused on laboratory aspects of drug concentration measurement then they changed more to the application of TDM in a clinical setting. Over its history, the Journal has provided its readership with the latest technological and scientific advances in TDM and has helped to drive changes in TDM that have directly impacted on patient care. These have varied from improvement in the quality of antimicrobial measurements through better identification of dosage regimens and TDM targets that help predict outcome and adverse events.

AB - Since the Journal was first published in 1975, papers addressing therapeutic drug monitoring (TDM) have been a regular feature. Initially they focused on laboratory aspects of drug concentration measurement then they changed more to the application of TDM in a clinical setting. Over its history, the Journal has provided its readership with the latest technological and scientific advances in TDM and has helped to drive changes in TDM that have directly impacted on patient care. These have varied from improvement in the quality of antimicrobial measurements through better identification of dosage regimens and TDM targets that help predict outcome and adverse events.

KW - therapeutic drug monitoring

KW - drug assay

KW - antimicrobials

UR - http://jac.oxfordjournals.org/content/71/12/3330.abstract

U2 - 10.1093/jac/dkw408

DO - 10.1093/jac/dkw408

M3 - Editorial

SN - 0305-7453

VL - 71

SP - 3330

EP - 3332

JO - Journal of Antimicrobial Chemotherapy

JF - Journal of Antimicrobial Chemotherapy

IS - 12

ER -

Therapeutic drug monitoring in the past 40 years of the JAC

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this